Business Description
Kangmei Pharmaceutical Co Ltd
ISIN : CNE0000017M1
Share Class Description:
SHSE:600518: Class ATotal Employee Number:
5,492Compare
Compare
Traded in other countries / regions
600518.China Index Membership
SSE Composite IndexCSI 300 Index IPO Date
2001-03-19Description
Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the trading of Chinese herbal medicines, production and sales of Chinese herbal medicine slices, Chinese patent medicine preparations, health foods, chemical drugs, and medical devices, modern pharmaceutical logistics system. The company is also engaged in medical equipment, property leasing and sales, and other services.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.07 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 5.01 | |||||
Interest Coverage | 5.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -0.37 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.5 | |||||
3-Year EPS without NRI Growth Rate | 42.4 | |||||
3-Year FCF Growth Rate | 50 | |||||
3-Year Book Growth Rate | 1.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.29 | |||||
9-Day RSI | 52.54 | |||||
14-Day RSI | 50.14 | |||||
3-1 Month Momentum % | -28.9 | |||||
6-1 Month Momentum % | -35.94 | |||||
12-1 Month Momentum % | -41.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.27 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 220.44 | |||||
Days Sales Outstanding | 175.7 | |||||
Days Payable | 227.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 0.18 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 20.9 | |||||
Operating Margin % | 1.91 | |||||
Net Margin % | -0.29 | |||||
EBITDA Margin % | 0.69 | |||||
FCF Margin % | -1.34 | |||||
OCF Margin % | 3.14 | |||||
ROE % | -0.2 | |||||
ROA % | -0.11 | |||||
3-Year ROIIC % | -162.59 | |||||
ROC (Joel Greenblatt) % | 1.02 | |||||
ROCE % | 0.44 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | 225 | |||||
PS Ratio | 4.7 | |||||
PB Ratio | 2.55 | |||||
Price-to-Tangible-Book | 2.76 | |||||
Price-to-Operating-Cash-Flow | 96.43 | |||||
EV-to-EBIT | 504.6 | |||||
EV-to-EBITDA | 504.6 | |||||
EV-to-Revenue | 3.48 | |||||
EV-to-FCF | -259.43 | |||||
Price-to-GF-Value | 0.92 | |||||
Price-to-Projected-FCF | 5.4 | |||||
Price-to-Median-PS-Value | 1.02 | |||||
Price-to-Graham-Number | 5.19 | |||||
| Price-to-Net-Current-Asset-Value | 22.5 | |||||
Earnings Yield (Greenblatt) % | 0.2 | |||||
FCF Yield % | -0.36 | |||||
Forward Rate of Return (Yacktman) % | -42.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kangmei Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 5,032.704 | ||
| EPS (TTM) (Â¥) | - | ||
| Beta | 0.5778 | ||
| 3-Year Sharpe Ratio | -0.68 | ||
| 3-Year Sortino Ratio | -0.92 | ||
| Volatility % | 27.02 | ||
| 14-Day RSI | 50.14 | ||
| 14-Day ATR (Â¥) | 0.055948 | ||
| 20-Day SMA (Â¥) | 1.3245 | ||
| 12-1 Month Momentum % | -41.43 | ||
| 52-Week Range (Â¥) | 1.16 - 2.27 | ||
| Shares Outstanding (Mil) | 13,828.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kangmei Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kangmei Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2015-06-16 | 23.51 (-5.87%) | ||
| 2:1 Stock Split | 2009-04-22 | 3.36 (+0.44%) | ||
| 1.5:1 Stock Split | 2008-03-04 | 2.56 (+5.18%) | ||
| 2:1 Stock Split | 2007-05-08 | 1.97 (-1.17%) | ||
| 1.5:1 Stock Split | 2006-05-18 | 0.58 (+2.15%) | ||
| 1.5:1 Stock Split | 2004-05-20 | 0.75 (-1.21%) |
Show
Entries
Kangmei Pharmaceutical Co Ltd Frequently Asked Questions
What is Kangmei Pharmaceutical Co Ltd(SHSE:600518)'s stock price today?
The current price of SHSE:600518 is ¥1.35. The 52 week high of SHSE:600518 is ¥2.27 and 52 week low is ¥1.16.
When is next earnings date of Kangmei Pharmaceutical Co Ltd(SHSE:600518)?
The next earnings date of Kangmei Pharmaceutical Co Ltd(SHSE:600518) is .
Does Kangmei Pharmaceutical Co Ltd(SHSE:600518) pay dividends? If so, how much?
Kangmei Pharmaceutical Co Ltd(SHSE:600518) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kangmei Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers